VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.81 Cr | ₹2.90 Cr | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr |
What is the latest Long Term Provisions ratio of VENUS REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹2.81 Cr |
| Mar2025 | ₹2.90 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.85 Cr |
| Mar2022 | ₹7.95 Cr |
How is Long Term Provisions of VENUS REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.81 Cr | -2.97 | |
| Mar2025 | ₹2.90 Cr | -71.74 | |
| Mar2024 | ₹10 Cr | 15.96 | |
| Mar2023 | ₹8.85 Cr | 11.21 | |
| Mar2022 | ₹7.95 Cr | - | |
Compare Long Term Provisions of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,162.8 Cr | -8.5% | 5.2% | 242.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -8.5% |
5.2% |
242.8% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses